These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17561693)

  • 1. [Identification and application of marker genes for differential diagnosis of chronic fatigue syndrome].
    Kawai T; Rokutan K
    Nihon Rinsho; 2007 Jun; 65(6):1029-33. PubMed ID: 17561693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of marker genes for differential diagnosis of chronic fatigue syndrome.
    Saiki T; Kawai T; Morita K; Ohta M; Saito T; Rokutan K; Ban N
    Mol Med; 2008; 14(9-10):599-607. PubMed ID: 18596870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profile exploration of a large dataset on chronic fatigue syndrome.
    Fang H; Xie Q; Boneva R; Fostel J; Perkins R; Tong W
    Pharmacogenomics; 2006 Apr; 7(3):429-40. PubMed ID: 16610953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic evaluation of the serotonergic system in chronic fatigue syndrome.
    Smith AK; Dimulescu I; Falkenberg VR; Narasimhan S; Heim C; Vernon SD; Rajeevan MS
    Psychoneuroendocrinology; 2008 Feb; 33(2):188-97. PubMed ID: 18079067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome.
    Rajeevan MS; Smith AK; Dimulescu I; Unger ER; Vernon SD; Heim C; Reeves WC
    Genes Brain Behav; 2007 Mar; 6(2):167-76. PubMed ID: 16740143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing patients with chronic fatigue from those with chronic fatigue syndrome: a diagnostic study in UK primary care.
    Darbishire L; Ridsdale L; Seed PT
    Br J Gen Pract; 2003 Jun; 53(491):441-5. PubMed ID: 12939888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: a detailed analysis of gene networks and clinical phenotypes.
    Kerr JR; Burke B; Petty R; Gough J; Fear D; Mattey DL; Axford JS; Dalgleish AG; Nutt DJ
    J Clin Pathol; 2008 Jun; 61(6):730-9. PubMed ID: 18057078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals.
    Buchwald D; Pearlman T; Umali J; Schmaling K; Katon W
    Am J Med; 1996 Oct; 101(4):364-70. PubMed ID: 8873506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood gene expression in postinfective fatigue syndrome following from three different triggering infections.
    Galbraith S; Cameron B; Li H; Lau D; Vollmer-Conna U; Lloyd AR
    J Infect Dis; 2011 Nov; 204(10):1632-40. PubMed ID: 21964398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the diagnosis of chronic fatigue syndrome.
    Solomon L; Reeves WC
    Arch Intern Med; 2004 Nov; 164(20):2241-5. PubMed ID: 15534161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic fatigue syndrome. More and more differential diagnoses suggest a new view of this syndrome].
    Merz S
    Lakartidningen; 2002 Aug; 99(34):3282-7. PubMed ID: 12362846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antinuclear antibodies in patients with chronic fatigue syndrome].
    Nishikai M
    Nihon Rinsho; 2007 Jun; 65(6):1067-70. PubMed ID: 17561698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian biomarker identification based on marker-expression proteomics data.
    Bhattacharjee M; Botting CH; Sillanpää MJ
    Genomics; 2008 Dec; 92(6):384-92. PubMed ID: 18657605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome.
    Vernon SD; Unger ER; Dimulescu IM; Rajeevan M; Reeves WC
    Dis Markers; 2002; 18(4):193-9. PubMed ID: 12590173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The chronic fatigue syndrome].
    Białyszewski A
    Psychiatr Pol; 1993; 27(6):601-11. PubMed ID: 8134494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME).
    Petty RD; McCarthy NE; Le Dieu R; Kerr JR
    PLoS One; 2016; 11(3):e0150904. PubMed ID: 26967895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated approach to infer causal associations among gene expression, genotype variation, and disease.
    Lee E; Cho S; Kim K; Park T
    Genomics; 2009 Oct; 94(4):269-77. PubMed ID: 19540336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemic neuromyasthenia and chronic fatigue syndrome in west Otago, New Zealand. A 10-year follow-up.
    Levine PH; Snow PG; Ranum BA; Paul C; Holmes MJ
    Arch Intern Med; 1997 Apr; 157(7):750-4. PubMed ID: 9125006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression correlates of unexplained fatigue.
    Whistler T; Taylor R; Craddock RC; Broderick G; Klimas N; Unger ER
    Pharmacogenomics; 2006 Apr; 7(3):395-405. PubMed ID: 16610950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric comorbidity in persons with chronic fatigue syndrome identified from the Georgia population.
    Nater UM; Lin JM; Maloney EM; Jones JF; Tian H; Boneva RS; Raison CL; Reeves WC; Heim C
    Psychosom Med; 2009 Jun; 71(5):557-65. PubMed ID: 19414619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.